Literature DB >> 21551470

Familial recurrence risks for multiple sclerosis in Australia.

C O'Gorman1, S Freeman, B V Taylor, H Butzkueven, S A Broadley.   

Abstract

BACKGROUND: Genetic susceptibility to multiple sclerosis (MS) has been recognised for many years. Considerable data exist from the northern hemisphere regarding the familial recurrence risks for MS, but there are few data for the southern hemisphere and regions at lower latitude such as Australia. To investigate the interaction between environmental and genetic causative factors in MS, the authors undertook a familial recurrence risk study in three latitudinally distinct regions of Australia.
METHODS: Immediate and extended family pedigrees have been collected for three cohorts of people with MS in Queensland, Victoria and Tasmania spanning 15° of latitude. Age of onset data from Queensland were utilised to estimate age-adjusted recurrence rates.
RESULTS: Recurrence risks in Australia were significantly lower than in studies from northern hemisphere populations. The age-adjusted risk for siblings across Australia was 2.13% compared with 3.5% for the northern hemisphere. A similar pattern was seen for other relatives. The risks to relatives were proportional to the population risks for each site, and hence the sibling recurrence-risk ratio (λ(s)) was similar across all sites. DISCUSSION: The familial recurrence risk of MS in Australia is lower than in previously reported studies. This is directly related to the lower population prevalence of MS. The overall genetic susceptibility in Australia as measured by the λ(s) is similar to the northern hemisphere, suggesting that the difference in population risk is explained largely by environmental factors rather than by genetic admixture.

Entities:  

Mesh:

Year:  2011        PMID: 21551470     DOI: 10.1136/jnnp.2010.233064

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics.

Authors:  Jw Lindsey; Tf Scott; Sg Lynch; Ss Cofield; F Nelson; R Conwit; T Gustafson; Gr Cutter; Js Wolinsky; Fd Lublin
Journal:  Mult Scler Relat Disord       Date:  2012-02-23       Impact factor: 4.339

2.  Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.

Authors:  Neslihan Akdemir; Murat Terzi; Nilden Arslan; Musa Onar
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

3.  An assessment of genetic counseling services for individuals with multiple sclerosis.

Authors:  Stephanie Skinner; Colleen Guimond; Rachel Butler; Emily Dwosh; Anthony L Traboulsee; A Dessa Sadovnick
Journal:  J Genet Couns       Date:  2014-07-05       Impact factor: 2.537

4.  Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.

Authors:  Helga Westerlind; Ryan Ramanujam; Daniel Uvehag; Ralf Kuja-Halkola; Marcus Boman; Matteo Bottai; Paul Lichtenstein; Jan Hillert
Journal:  Brain       Date:  2014-01-17       Impact factor: 13.501

Review 5.  Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

Authors:  Cullen O'Gorman; Robyn Lucas; Bruce Taylor
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

6.  Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.

Authors:  Sharareh Eskandarieh; Narges Sistany Allahabadi; Malihe Sadeghi; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2018-02-07       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.